Table 3.
NCD | Nationality | 18–29 years | 30–39 years | 40–49 years | 50–59 years | ≥60 years | N | Crude rate (/1000) | Age-adjusted rate (/1000) * |
||
Cardiovascular disease | Coronary heart disease and its complications | Qatari | 0.16 | 0.68 | 4.96 | 18.33 | 65.15 | 1284 | 11.92 | 15.07 | |
Non-Qatari | Northern Africa | 0.2 | 1 | 5.37 | 22.57 | 55.72 | 590 | 8.24 | 14.19 | ||
Sub-Saharan Africa | 0 | 0.24 | 2.35 | 5.98 | 44.97 | 26 | 2.65 | 9.16 | |||
Latin America and the Caribbean | 0 | 0 | 0 | 0 | (66.67) | 2 | 5.22 | (11.59) | |||
Northern America | 0 | 0 | 6.91 | 18.71 | 69.16 | 39 | 16.09 | 15.99 | |||
Eastern and Central Asia | 0 | 0 | 11.36 | (0) | (47.62) | 2 | 4.23 | (10.37) | |||
South-Eastern Asia | 0 | 0.24 | 2.22 | 4.41 | 24.43 | 57 | 1.57 | 5.35 | |||
Southern Asia | 0.04 | 0.94 | 6.61 | 26.63 | 81.05 | 1447 | 11.3 | 19.35 | |||
Western Asia (excluding Qatar) | 0.11 | 0.55 | 5.77 | 22.56 | 74.28 | 700 | 11.73 | 17.37 | |||
Eastern Europe | 0 | 0 | 0 | 0 | (105.26) | 4 | 5.9 | (18.29) | |||
Northern Europe | 0 | 0 | 1.46 | 6.77 | 15.08 | 7 | 2.97 | 3.87 | |||
Southern Europe | 0 | 0 | 0 | 8.47 | (46.51) | 3 | 3.58 | (9.3) | |||
Western Europe | 0 | 0 | 5.68 | 0 | (88.89) | 5 | 8.83 | (16.49) | |||
Australasia | 0 | 0 | 0 | 28.3 | (46.51) | 5 | 12.85 | (12.16) | |||
Non-Qatari (total) | 0.08 | 0.74 | 5.37 | 22.14 | 70.34 | 2887 | 9.21 | 16.59 | |||
Thrombotic/haemorrhagic stroke | Qatari | 0.05 | 0.13 | 0.73 | 1.26 | 5.45 | 112 | 1.04 | 1.3 | ||
Non-Qatari | Northern Africa | 0 | 0.11 | 0.71 | 0.99 | 3.08 | 38 | 0.53 | 0.83 | ||
Sub-Saharan Africa | 0 | 0.24 | 1.18 | 0 | 7.94 | 6 | 0.61 | 1.65 | |||
Latin America and the Caribbean | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Northern America | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Eastern and Central Asia | 0 | 0 | 0 | (0) | (0) | 0 | 0 | (0) | |||
South-Eastern Asia | 0 | 0 | 0.61 | 0.29 | 1.53 | 8 | 0.22 | 0.42 | |||
Southern Asia | 0.11 | 0.16 | 0.41 | 1.74 | 3.4 | 84 | 0.66 | 0.98 | |||
Western Asia (excluding Qatar) | 0.06 | 0.05 | 0.47 | 1.2 | 3.9 | 40 | 0.67 | 0.97 | |||
Eastern Europe | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Northern Europe | 0 | 0 | 0 | 2.26 | 0 | 1 | 0.42 | 0.33 | |||
Southern Europe | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Western Europe | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Australasia | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Non-Qatari (total) | 0.06 | 0.11 | 0.52 | 1.28 | 3.38 | 177 | 0.56 | 0.91 | |||
Peripheral vascular disease | Qatari | 0.05 | 0.04 | 0.11 | 0.27 | 1.09 | 24 | 0.22 | 0.27 | ||
Non-Qatari | Northern Africa | 0.07 | 0.19 | 0.39 | 0.66 | 0.21 | 19 | 0.27 | 0.27 | ||
Sub-Saharan Africa | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Latin America and the Caribbean | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Northern America | 0 | 0 | 0 | 1.7 | 0 | 1 | 0.41 | 0.25 | |||
Eastern and Central Asia | 0 | 0 | 0 | (0) | (0) | 0 | 0 | (0) | |||
South-Eastern Asia | 0 | 0.06 | 0 | 0 | 3.05 | 3 | 0.08 | 0.54 | |||
Southern Asia | 0 | 0 | 0.24 | 0.39 | 0.88 | 22 | 0.17 | 0.25 | |||
Western Asia (excluding Qatar) | 0.06 | 0.05 | 0.19 | 0.15 | 1.87 | 17 | 0.28 | 0.41 | |||
Eastern Europe | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Northern Europe | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Southern Europe | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Western Europe | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Australasia | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | |||
Non-Qatari (total) | 0.03 | 0.06 | 0.22 | 0.38 | 1.04 | 62 | 0.2 | 0.29 |
*Figures (rates) enclosed within parentheses were based (or one of its components) on <50 unweighted observations.